日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Functional Role of COP1 Gene in Hepatocellular Carcinoma Lipid Metabolism and Stemness.

COP1基因在肝细胞癌脂质代谢和干性中的功能作用。

期刊:Genes to Cells
影响因子:1.3
doi:10.1111/gtc.70108
Jeon Eun-Hye, Bae An-Na, Lee Hajin, Park Keon Uk, Shin Hyun Mu, Park Jong Ho, Kim Kwang Seok, Park In-Chul, Lee Yun-Han
细胞生物学
发表日期：2026
文献求助 收藏

Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression

抑制 VDAC1 寡聚化可通过抑制线粒体 ROS 来阻止半胱氨酸缺乏引起的铁死亡

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-024-07216-1
Se-Kyeong Jang #, Se Hee Ahn #, Gyeongmi Kim, Selim Kim, Jungil Hong, Ki Soo Park, In-Chul Park, Hyeon-Ok Jin
细胞生物学
GFP
发表日期：2024
文献求助 收藏

Solubilized curcuminoid complex prevents extensive immunosuppression through immune restoration and antioxidant activity: Therapeutic potential against SARS-CoV-2 (COVID-19)

可溶性姜黄素复合物通过免疫修复和抗氧化活性防止广泛的免疫抑制：针对 SARS-CoV-2（COVID-19）的治疗潜力

期刊:International Immunopharmacology
影响因子:4.8
doi:10.1016/j.intimp.2022.109635
Woo Sik Kim, Seong-Hun Jeong, Ki-Won Shin, Hyeon Jin Lee, Ji-Young Park, In-Chul Lee, Hyung Jae Jeong, Young Bae Ryu, Hyung-Jun Kwon, Woo Song Lee
免疫
新冠
发表日期：2023
文献求助 收藏

Survival analysis of breast cancer patients after diagnosis of second primary malignancies, focusing on the second primary hematologic malignancy

对乳腺癌患者确诊第二原发性恶性肿瘤后的生存分析，重点关注第二原发性血液系统恶性肿瘤

期刊:Annals of Surgical Treatment and Research
影响因子:1.6
doi:10.4174/astr.2023.105.1.1
Kim, Hyung Jin; Lee, Juhyeon; Park, In-Chul; Han, Yireh; Seong, Min-Ki; Noh, Woo Chul; Kang, Hye Jin; Kim, Hyun-Ah; Park, Chan Sub
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen?

对于接受促性腺激素释放激素激动剂和三苯氧胺治疗的 N0 或 N1 期内分泌敏感型乳腺癌患者，是否可以省略化疗？

期刊:Annals of Surgical Treatment and Research
影响因子:1.6
doi:10.4174/astr.2023.105.1.31
Lee, Juhyeon; Park, Chan Sub; Oh, Jeong Hun; Park, In-Chul; Seong, Min-Ki; Noh, Woo Chul; Kim, Hyun-Ah
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Fabrication, Structure, and Properties of Nonwoven Silk Fabrics Prepared with Different Cocoon Layers

不同茧层非织造丝织物的制备、结构和性能

期刊:International Journal of Molecular Sciences
影响因子:0.7
doi:10.3390/ijms241411485
Yun Yeong Choi, Mi Jin Jang, Byung-Dae Park, In Chul Um
信号转导
发表日期：2023
文献求助 收藏

Structural Characteristics and Properties of Redissolved Silk Sericin

复溶丝胶的结构特征与性能

期刊:Polymers
影响因子:
doi:10.3390/polym15163405
Hye Gyeoung Lee, Mi Jin Jang, Byung-Dae Park, In Chul Um
信号转导
发表日期：2023
文献求助 收藏

Correction to: Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin

更正：二甲双胍通过 ATF4 诱导的 REDD1 和 Sestrin2 表达抑制 mTORC1

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-08584-z
Jang, Se-Kyeong; Hong, Sung-Eun; Lee, Da-Hee; Kim, Ji-Young; Kim, Ji Yea; Ye, Sang-Kyu; Hong, Jungil; Park, In-Chul; Jin, Hyeon-Ok
mTOR
REDD1
ATF4
RED
ORC1
发表日期：2021
文献求助 收藏

Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status

预测辅助芳香化酶抑制剂治疗对磷酸化S6K1表达状态的绝经后乳腺癌患者的益处

期刊:Journal of Breast Cancer
影响因子:2.4
doi:10.4048/jbc.2020.23.e5
Choi, Jihye; Park, Chan Sub; Seong, Min-Ki; Seol, Hyesil; Kim, Jae-Sung; Park, In-Chul; Noh, Woo Chul; Kim, Hyun-Ah
肿瘤
肿瘤免疫
信号转导
乳腺癌
磷酸化
发表日期：2020
文献求助 收藏

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer

pS6K1作为GnRH激动剂治疗绝经前乳腺癌的疗效标志物

期刊:Endocrine Connections
影响因子:2.8
doi:10.1530/EC-19-0101
Park, Chan Sub; Choi, Jihye; Seong, Min-Ki; Hong, Sung-Eun; Kim, Jae-Sung; Park, In-Chul; Seol, Hyesil; Noh, Woo Chul; Kim, Hyun-Ah
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏